Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.

TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm expects ...

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

Vagus Nerve Stimulation therapy is a treatment for epilepsy that involves a stimulator (or 'pulse generator') which is connected, inside the body, to the left vagus nerve in the neck. The stimulator ...

JetBlue is adding four new domestic and three international destinations to its schedule for summer flights departing from Boston Logan International Airport.The airline boasts that the seasonal ...

Bolt Acquisition Deal Drives BSX Stock Close to 52-Week High Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently ...

The private nonprofit that protects Franklin Park says the city of Boston can renovate White Stadium as a “high-quality, fully-public high school” sports venue for “a fraction of the cost ...